During the State of the Union address tonight, President Trump is expected to call for an end to the spread of HIV in the U.S. by 2030. There’s a drug already on the market that could help make that a reality. It’s called Truvada — otherwise known as PrEP (for Pre-Exposure Prophylaxis) — and when taken as a preventive, it can drastically reduces transmission of HIV. New York City health officials already credit it with playing a major role in cutting the rate of new HIV infections in the five boroughs by 18 percent. The downside? It can cost upward of $1,600 a month.
Click the audio player above to hear the full story.
If you’re a member of your local public radio station, we thank you — because your support helps those stations keep programs like Marketplace on the air. But for Marketplace to continue to grow, we need additional investment from those who care most about what we do: superfans like you.
Your donation — as little as $5 — helps us create more content that matters to you and your community, and to reach more people where they are – whether that’s radio, podcasts or online.
When you contribute directly to Marketplace, you become a partner in that mission: someone who understands that when we all get smarter, everybody wins.